---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-008984"
form_type: "8-K"
ticker: "PHIO"
cik: "0001533040"
company_name: "Phio Pharmaceuticals Corp."
filed_at: "2024-12-26T23:59:59+00:00"
generated_at: "2026-05-28T23:17:21.928069+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Phio raises ~$0.48M in registered direct offering of 240K shares at $2.00/share with warrants

## Summary
- Sold 240,000 shares of common stock at $2.00/share for gross proceeds of ~$0.48M; net ~$0.48M after expenses.
- Issued warrants to purchase up to 240,000 additional shares at $2.00/share, exercisable immediately, expiring in 5 years.
- H.C. Wainwright acted as placement agent; cash fees of 7.5% of gross proceeds plus management fee and warrants.
- Proceeds to be used for working capital and general corporate purposes.
- Closing occurred on Dec 24, 2024.

## SEC filing metadata
- accession: 0001683168-24-008984
- form_type: 8-K
- ticker: PHIO
- cik: 0001533040
- company_name: Phio Pharmaceuticals Corp.
- filed_at: 2024-12-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533040/000168316824008984/0001683168-24-008984-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533040/000168316824008984/phio_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-008984
- JSON: https://secwatch.observer/filing/0001683168-24-008984.json
- Plain text: https://secwatch.observer/filing/0001683168-24-008984.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.